Share |

PrintPrintable version

Campaign to “Stop the Stigma” of Mental Illness—Is a Pharmaceutical Marketing Campaign

| | Comments (0) | TrackBacks (0)

Commission on Human Rights, (CCHR) has launched a new video to expose the hypocracy of the pharmaceutically driven campaign to “Stop the Stigma” of mental illness. With its seemingly altruistic sounding agenda to eliminate “stigma” the fact is the real “stigmatization” is coming from those behind this campaign—pharma, psychiatry and pharma-funded front groups such as NAMI and CHADD to name but a few. There are currently 20 million kids & adolescents labeled with mental “disorders” that are based solely on a checklist of behaviors, no brain scans, x-rays, genetic or blood tests can prove they are “mentally ill”, yet they are being stigmatized with psychiatric labels, which will be part of their permanent medical record, and prescribed dangerous, life-threatening psychiatric drugs.

Child drugging is a $4.8 billion-a-year industry, and the industry knows where to put its funding to get the most bang for its buck. For example, take NAMI’s campaign to stop the “stigma” and “end discrimination” against the mentally ill—the “Founding Sponsors” were Abbott Labs, Bristol-Myers Squibb, Eli Lilly, Janssen, Pfizer, Novartis, SmithKline Beecham and Wyeth-Ayerst Labs. (For an in-depth look at what else Pharma funds and how this funding not only helps set mental health policies but campaigns such as this, read Pharmaceutical Industry Agenda Setting in Mental Health Policies at the bottom of this post)

The real stigmatization is coming from those that benefit from labeling behaviors as diseases to be “cured” or “treated” despite the complete lack of medical/biological evidence to support them. George Orwell coined the term Doublespeak, meaning words redefined to mislead, distort and disguise, and no better example exists than psychiatry’s pathologizing and redefining behaviors into mental “illness”. For example, If an adolescent is strong willed, this is redefined as “oppositional defiant disorder.” If a kid acts like a kid, sometimes losing pencils or toys, or acting “on the go” then this has been pathologized into “ADHD.” If a teenager has normal adolescent mood swings, then this has been repackaged as “bi-polar disorder.” And shyness? Doesn’t exist. It is now called “social anxiety disorder.” Moreover, once labeled, these kids are stigmatized for life.

Psychiatric labels are the stigma.

Various canned press releases and “studies” circulated by the Psycho/Pharmaceutical industry profess, “more people now believe that illnesses like schizophrenia and depression are caused by chemical imbalances in the brain.” This is marketing at its best—say people believe in a chemical imbalance so you don’t have to bother pointing out the fact that there is no chemical imbalance . How can the layperson be sure of this? It’s simple. Find one person who has a lab test showing their chemical imbalance. Not one of the millions of people taking drugs to cure their “chemical imbalance” has a lab test showing they have an imbalance.

So when it comes to “stigmatization” one need look no further than those who benefit from labels which are simply based on opinion—not science, and not medicine. Now it really doesn’t take a rocket scientist to figure that out… does it?

Watch video: Psychiatry—Stigmatizing Kids with Bogus ‘Mental Disorders’

For more information about pharmaceutical front groups see this:

For an in-depth look at this topic, read Pharmaceutical Industry Agenda Setting in Mental Health Policies

  • Currently 5/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 5/5 (2 votes cast)

0 TrackBacks

Listed below are links to blogs that reference this entry: Campaign to “Stop the Stigma” of Mental Illness—Is a Pharmaceutical Marketing Campaign.

TrackBack URL for this entry:

Leave a comment

Health Supreme News

Powered by Movable Type 5.13-en

Receive updates

Subscribe to get updates of this site by email:

Enter your Email

Preview | Powered by FeedBlitz

Other sites of ours